About the HAS-BLED Score Calculator
The HAS-BLED score estimates the one-year risk of major bleeding in patients with atrial fibrillation (AF) who are taking, or being considered for, oral anticoagulation. It was developed by Pisters and colleagues from 3,978 real-world AF patients with complete one-year follow-up in the Euro Heart Survey and published in Chest in 2010. Each letter of the acronym is a risk factor worth one point, for a total from 0 to 9.
This calculator is for clinicians, pharmacists, nurses and students who need a quick, structured bleeding-risk tally alongside a stroke-risk score such as CHA₂DS₂-VASc. Tick each factor that applies and you get the total, the commonly used risk category (a score of 3 or more is generally regarded as high risk) and the major bleeding rate per 100 patient-years observed at that score in the original validation cohort.
A high HAS-BLED score is not by itself a reason to withhold anticoagulation. Guidelines use it to flag patients who need closer review and to prompt correction of modifiable factors such as uncontrolled blood pressure, labile INR, concomitant antiplatelet or NSAID use and excess alcohol. The score was validated in adults with AF; it does not tell you which therapy to use.
With the default inputs, the has-bled score is 2 / 9. Change any value above to recalculate instantly.
How to use the has-bled score calculator
- 1Check the patient’s current blood pressure and tick hypertension only if systolic is above 160 mmHg.
- 2Tick abnormal renal and abnormal liver function separately if each meets its definition.
- 3Add prior stroke, prior bleeding or predisposition, and labile INR if on warfarin.
- 4Tick age over 65, antiplatelet/NSAID use and alcohol of 8 or more drinks a week where they apply.
- 5Read the total, risk category and reported bleeding rate, and review the modifiable factors listed.
Formula and method
Each of the nine risk factors scores one point when present, giving a total from 0 to 9. Abnormal renal and abnormal liver function count separately, as do drug use (antiplatelet agents or NSAIDs) and alcohol excess, which is why the acronym has seven letters but nine points.
In the Euro Heart Survey validation cohort the annual major bleeding rate rose from about 1 per 100 patient-years at scores of 0–1 to 3.74 at a score of 3, 8.70 at 4 and 12.5 at 5. Major bleeding was defined as intracranial bleeding, bleeding requiring hospitalisation, a significant haemoglobin fall, or transfusion. Rates in other populations and with direct oral anticoagulants differ.
- H
- Uncontrolled hypertension, systolic blood pressure > 160 mmHg
- A
- Abnormal renal and/or liver function (1 point each)
- S
- Previous stroke
- B
- Bleeding history or predisposition
- L
- Labile INR on a vitamin K antagonist
- E
- Elderly, age over 65
- D
- Drugs (antiplatelets, NSAIDs) and/or alcohol excess (1 point each)
Worked examples
72-year-old with uncontrolled hypertension
Two factors apply: systolic pressure above 160 mmHg (H) and age over 65 (E), so the score is 2. In the validation cohort a score of 2 corresponded to 1.88 major bleeds per 100 patient-years.
Prior stroke, labile INR and aspirin use
Stroke (1) + labile INR (1) + age over 65 (1) + antiplatelet use (1) = 4. The reported bleeding rate at a score of 4 was 8.70 per 100 patient-years; labile INR and aspirin are modifiable.
Every factor present
With all nine factors ticked the score reaches its maximum of 9. Very few patients in the study scored 6 or more, so no reliable bleeding rate is shown above a score of 5.
Frequently asked questions
What is a high HAS-BLED score?+
A score of 3 or more is generally considered high bleeding risk. It signals the need for caution, regular review and correction of modifiable risk factors, rather than an automatic reason to avoid anticoagulation.
What does HAS-BLED stand for?+
Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile INR, Elderly (over 65) and Drugs/alcohol. Renal, liver, drugs and alcohol each count one point, giving a maximum of 9.
How is HAS-BLED different from CHA2DS2-VASc?+
CHA₂DS₂-VASc estimates stroke risk in atrial fibrillation, while HAS-BLED estimates bleeding risk on anticoagulation. They are usually calculated together so stroke prevention benefit can be weighed against bleeding risk.
Does labile INR apply to patients on DOACs?+
The labile INR item was designed for patients on vitamin K antagonists such as warfarin, defined by unstable or high INRs or poor time in therapeutic range. Patients on direct oral anticoagulants usually score 0 for this item.
Which patients was HAS-BLED validated in?+
It was derived and validated in 3,978 adults with atrial fibrillation in the Euro Heart Survey, and has since been tested in many AF and anticoagulated cohorts. It is not designed for patients without AF or for children.
For healthcare professionals and education only. This calculator implements a published formula or score but is not a diagnosis and does not replace clinical judgment. Verify inputs and results against the original source before using them in patient care.